A Win For Hancock Jaffe Laboratories, Inc.

Wed, Jan 08, 2020 at 05:30 PM
A Win For Hancock Jaffe Laboratories, Inc.

Hancock Jaffe Laboratories, Inc. (HJLI:NASDAQ) rocketted at $0.72, a gain of 31.1%. On Tue 07 Jan 20, HJLI:NASDAQ hit a New 2-Week Intraday High of $0.58. The stock got featured on our News Catalysts scanner on Wed 08 Jan 20 at 09:17 AM in the 'RECOMMENDATION' category. From Mon 16 Dec 19, the stock recorded 42.86% Up Days and 60.00% Green Days

About Hancock Jaffe Laboratories, Inc. (HJLI:NASDAQ)

Hancock Jaffe Laboratories Inc development stage medical device company. It develops and sells biological tissue solutions to treat patients with coronary, vascular, end stage renal and peripheral arterial diseases in the United States and Europe.

Share
Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.